Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan

被引:0
作者
Chaochen Wang
Toshihiko Aranishi
Catherine Reed
Peter Anderson
Jenny Austin
Victoria A. Davis
Emily Quinones
James Piercy
机构
[1] Eli Lilly Japan K.K.,
[2] Eli Lilly and Company Limited,undefined
[3] Adelphi Real World,undefined
来源
Dermatology and Therapy | 2023年 / 13卷
关键词
Atopic dermatitis; Disconnect; Japan; Patient; Physician; Satisfaction; Therapeutics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:505 / 522
页数:17
相关论文
共 161 条
[1]  
Simpson EL(2020)Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial JAMA Dermatol 156 44-56
[2]  
Paller AS(2019)Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families Child (Basel) 6 133-36
[3]  
Siegfried EC(2006)Burden of atopic dermatitis in Canada Int J Dermatol 45 31-72
[4]  
Boguniewicz M(2011)Current status of atopic dermatitis in Japan Asia Pac Allergy 1 64-1606
[5]  
Sher L(2021)Comparison of the time course of atopic dermatitis from birth to 19 years old among generations of patients in Japan J Dermatol 48 1602-121
[6]  
Gooderham MJ(2003)Prevalence of atopic dermatitis in Japanese adults Br J Dermatol 148 117-1060
[7]  
Beck LA(2012)Guidelines for treatment of atopic eczema (atopic dermatitis) Part I J Eur Acad Dermatol Venereol 26 1045-1145
[8]  
Guttman-Yassky E(2016)Clinical practice guidelines for the management of atopic dermatitis 2016 J Dermatol 43 1117-247
[9]  
Pariser D(2017)Japanese guidelines for atopic dermatitis 2017 Allergol Int 66 230-119
[10]  
Blauvelt A(2021)Real-world treatment patterns of patients with atopic dermatitis in Japan: analysis of the JMDC claims database J Cutane Immunology and Allergy 4 109-699